What they were paid
Kymera Therapeutics Director Compensation Table · the one fiscal year held| Fiscal year | Cash fees | Stock awards | Option awards | Other | Total |
|---|---|---|---|---|---|
| FY2025 | — | $0 | — | $0 | — |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Kymera Therapeutics, Inc. DEF 14A filed April 29, 2026, accession 0001193125-26-191495, and prior-year filings. Open the filing on EDGAR.
How this board is paid
company policy · FY2025Kymera Therapeutics pays directors a $40,000 cash retainer.
The rest of the Kymera Therapeutics board
FY2025 · as the company reported each| Director | Role | FY2025 total |
|---|---|---|
| Elena Ridloff | Independent Director | $632,996 |
| Felix J. Baker | Independent Director | $636,871 |
| Gorjan Hrustanovic Ph.D | Independent Director | $617,996 |
| Jeffrey Albers | Independent Director | $637,996 |
| John Maraganore | Independent Director | $620,496 |
| Nello Mainolfi | Director | $0 |
| Pamela Esposito | Independent Director | $630,579 |
| Victor Sandor | Independent Director | — |
The full Kymera Therapeutics compensation record
free company briefThis page is one director within Kymera Therapeutics's record. The company brief lists every named executive and director, each linking to their own page.
Velarion Pro: every company page, peer tools and exports, one seat